Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV

Cardiovascular disease (CVD) remains the leading cause of death and disability globally. A wide range of CVDs have been reported, each of which diverges significantly, exhibiting sophisticated types of pathogenesis (e.g., inflammatory, oxidative stress, and disorders in cardiomyocyte metabolism). Co...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomedicine & pharmacotherapy 2023-12, Vol.168, p.115752-115752, Article 115752
Hauptverfasser:	Xu, Zehui, Zhou, Houle, Zhang, Yihan, Cheng, Ziji, Wan, Melisandre, Qin, Wanting, Li, Peiyu, Feng, Jiaming, Shao, Shuijin, Xue, Wenlong, Guo, Haidong, Liu, Baonian
Format:	Artikel
Sprache:	eng
Schlagworte:	Astragaloside IV Cardiovascular diseases Pharmacological mechanism Traditional Chinese medicine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!